This article has been updated from a previous version to include comments made during Fluidigm's earnings call.

NEW YORK (GenomeWeb) – Fluidigm said Thursday after the close of the market that its first quarter revenues decreased 12 percent year over year.

For the three months ended March 31, the South San Francisco, California-based single-cell biology firm brought in revenues of $25.5 million compared to $29.0 million in the first quarter of 2016. Total revenues edged out the consensus Wall Street estimate of $25.0 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Sponsored by

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.